APA

Degirmenci M., Karaca B., Gorumlu G., Durusoy R., Demir Piskin G., Bozkurt M. T., Cirak Y., Tunali D., Karabulut B., Sanli U. A. & Uslu R. (20101230). Efficacy and safety of bevacizumab plus capecitabine and irinotecan regimen for metastatic colorectal cancer. : Medical oncology (Northwood, London, England).

Chicago

Degirmenci M, Karaca B, Gorumlu G, Durusoy R, Demir Piskin G, Bozkurt M T, Cirak Y, Tunali D, Karabulut B, Sanli U A and Uslu R. 20101230. Efficacy and safety of bevacizumab plus capecitabine and irinotecan regimen for metastatic colorectal cancer. : Medical oncology (Northwood, London, England).

Harvard

Degirmenci M., Karaca B., Gorumlu G., Durusoy R., Demir Piskin G., Bozkurt M. T., Cirak Y., Tunali D., Karabulut B., Sanli U. A. and Uslu R. (20101230). Efficacy and safety of bevacizumab plus capecitabine and irinotecan regimen for metastatic colorectal cancer. : Medical oncology (Northwood, London, England).

MLA

Degirmenci M, Karaca B, Gorumlu G, Durusoy R, Demir Piskin G, Bozkurt M T, Cirak Y, Tunali D, Karabulut B, Sanli U A and Uslu R. Efficacy and safety of bevacizumab plus capecitabine and irinotecan regimen for metastatic colorectal cancer. : Medical oncology (Northwood, London, England). 20101230.